Fostering interactions among industry, investors, government, and academia

Chalk Talk with Axonis Therapeutics

Time: 12:30 PM - 1:15 PM
Location: Virtual
Register Here

AXONIS Therapeutics is advancing breakthrough drug discoveries to develop first-in-class therapies for currently incurable neurological disorders, in order to make a real difference for patients, their families, and the global healthcare system. Operational since 2020, AXONIS is a seed-stage therapeutics company based in LabCentral and has assembled a team of world-leading innovators, serial entrepreneurs, successful drug developers, driven scientists and passionate patient advocates. Adult-onset central nervous system (CNS) disorders are an urgent, unmet, global and growing burden, especially as more people are living longer. Neuron degeneration and excitation/inhibition imbalances are fundamental problems of many debilitating neurological disorders. AXONIS is developing a pipeline of neuron-reviving therapeutics which enable an intrinsic ability of CNS neurons to: (1) resist neurodegeneration, (2) restore excitation/inhibition balance, and (3) regenerate.

Tune in to hear from Chief Scientific Officer, Shane Hegarty! Register by Friday, October 22 to receive a virtual Grubhub credit to utilize during the time of the event.